🚨 New episode alert! We're diving into the new ISTH-ASH guidelines on pediatric VTE with two experts who helped shape them: Dr. Paul Monagle (panel Chair) & Dr. Leslie Raffini. Tune in as they break down key recommendations. 🎧 Listen now: bit.ly/3FdbVZ7

It’s an honor to be part of these guidelines. I truly enjoyed working with such an exceptional panel.

Excited to be part of this! June 12, 2025 | 5:00 PM - 5:30 PM ET | Virtual Livestream; OnDemand to follow hfsa.org/cardio-town-ha…

A pilot study conducted at KU Medical Center suggests that creatine can improve cognition in people with Alzheimer’s disease. Creatine is a dietary supplement routinely used by athletes to boost energy in muscles and enhance athletic performance. kumc.edu/about/news/new…

Happy to share our systematic review & meta-analysis on thrombolysis outcomes in pediatric VTE, now published in Blood Advances! This work informed ASH ISTH guidelines. Grateful to all authors, special thanks to Reem Mustafa ashpublications.org/bloodadvances/…

Honored to be named a 2025 Hematology Research All-Star! This recognition by @Avant-garde Health highlights the top 5% of physicians for impactful research. Grateful to my collaborators and mentors, this is a shared achievement! BU Amyloidosis Center Boston Medical Center Boston U Chobanian & Avedisian School of Medicine

Diagnosing amyloidosis can be tricky. So what if your patient actually has more than 1 type of amyloidosis? pubmed.ncbi.nlm.nih.gov/40526008/ "Our findings underscore the complexity of clinical presentation in amyloidosis, as multiple amyloid types can co-exist in a single individual and

Advocates suggest administrative real-world data can substitute for #RCTs and offer propensity matching to reduce bias. But results often fail to correspond: #BMJ study showed direction of effect differed in 31% & CI failed to include #RCT estimate in 56% pubmed.ncbi.nlm.nih.gov/26858277/

Another disappointment for #AL #amyloidosis #depleters: CARES didn’t meet its primary endpoint. What exactly was the prespecified subgroup that showed benefit? 🤔 Does this mean anything for #ATTR depleters? Time (and full data) will tell. reuters.com/business/healt…

🎉Certified Guideline Methodologist! GIN Member McMaster University INGUIDE Program (Guideline Int'l Network+McMaster) #EBM #guidelines #inguide

🩸Hematology For the Non-Hematologist🩸 (A practical educational series for internal medicine trainees and physicians) Episode 4 - Febrile Neutropenia? Here’s your assessment and plan. Listen up - 🧵

🎗️Oncology for The Non-Oncologist🎗️ (A practical educational series for internal medicine trainees and physicians) Episode 5: Hypercalcemia of Malignancy… A Fact or a Myth? 🤔💭 Listen up - 🧵

ISA is now accepting applications for the 2026–2027 Fellowship Program! This prestigious opportunity provides hands-on training in amyloidosis care at high-volume, expert centers and supports future leaders in the field. Learn more: isaamyloidosis.org/fellowships/

Happy to share our work on Updating Clinical Guidelines with Limited Evidence as part of ASH ISTH Peds VTE Treatment Guidelines is now published in Blood Advances! Grateful to all authors, special thanks to Reem Mustafa doi.org/10.1182/blooda…

🩸Hematology for The Non-Hematologist🩸 (A practical educational series for internal medicine trainees and physicians) Episode 7: Leukemia and Lymphoma Alphabet Soups: AML, CLL, CML, ALL, acute vs chronic - myeloid vs lymphoid. Let’s decode all this. Listen up - 🧵

👏👏👏

The Perugini Grades After 20 Years: Time for a Modern Framework. With Wael Jaber Editorial for excellent paper from Sharmila Dorbala group showing similar prognosis between grade 2 and 3 in ATTR-CM sciencedirect.com/science/articl… journalofnuclearcardiology.org/article/S1071-…

1/11 Pleased to share that our multi-institutional study “Integrated Molecular and Clinical Characterization of Pulmonary Large Cell Neuroendocrine Carcinoma” was published today. This represents the most comprehensive analysis of LCNEC to date. Grateful for the support of

Cardiologists: marked safe from being replaced by AI today ✅

The 2025 ATTR Early-Career Research Forum is back on! Two $100K Wiesman Awards will be granted - fellows and early career, I strongly encourage you to apply. We want to see your work! cornerstonemeded.com/attr-ecrf/ #Cardiotwitter